We are live on ! Find out more
RNTX

Rein Therapeutics

19 hedge funds and large institutions have $20.7M invested in Rein Therapeutics in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.09% more ownership

Funds ownership: 0%2.09% (+2.1%)

Holders
19
Holders Change
+19
Holders Change %
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
1
Bank of America
North Carolina
$7.45M +$7.33M +33,409 New
Jennison Associates
2
Jennison Associates
New York
$2.79M +$2.74M +12,500 New
CS
3
Candriam SCA
Luxembourg
$1.67M +$1.65M +7,500 New
SFM
4
Sphera Funds Management
Israel
$1.39M +$1.37M +6,250 New
Millennium Management
5
Millennium Management
New York
$1.36M +$1.34M +6,104 New
NC
6
Nexthera Capital
New York
$1.27M +$1.25M +5,705 New
ECM
7
Endurant Capital Management
California
$993K +$978K +4,455 New
MIM
8
Monashee Investment Management
Massachusetts
$836K +$823K +3,750 New
HCM
9
Highbridge Capital Management
New York
$562K +$554K +2,522 New
Norges Bank
10
Norges Bank
Norway
$558K +$549K +2,500 New
Goldman Sachs
11
Goldman Sachs
New York
$418K +$412K +1,875 New
LCM
12
Laurion Capital Management
New York
$335K +$329K +1,500 New
MCM
13
Masters Capital Management
Georgia
$335K +$329K +1,500 New
Neuberger Berman Group
14
Neuberger Berman Group
New York
$279K +$274K +1,250 New
Citadel Advisors
15
Citadel Advisors
Florida
$141K +$139K +634 New
Tudor Investment Corp
16
Tudor Investment Corp
Connecticut
$112K +$110K +500 New
ZP
17
Zimmer Partners
New York
$112K +$110K +500 New
Vanguard Group
18
Vanguard Group
Pennsylvania
$111K +$110K +500 New
PMFA
19
Plante Moran Financial Advisors
Michigan
$3K +$3.29K +15 New

RNTX Hedge Fund Activity: Q2 2017 in Review

19 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q2 2017, worth a combined $20.7M.

Buyers outnumbered sellers: 19 funds opened new RNTX positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $7.33M.

  • 19 institutional investors held Rein Therapeutics (RNTX) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $20.7M of Rein Therapeutics stock for Q2 2017.
  • 19 funds opened new Rein Therapeutics positions in Q2 2017 and 0 closed out, a net change of +19 holders.
  • The largest Rein Therapeutics buyer in Q2 2017 was Bank of America, an estimated $7.33M added.

Based on aggregated 13F filings for Q2 2017.